Figure 2

High-dose STZ treatment causes a greater increase in blood glucose levels at early but not late time points compared to low dose STZ. Shown are mouse blood glucose levels measured at 4 and 19 days post-injection (dpi) for control (white bar), 40 mg/kg STZ (low dose, gray bar), or 60 mg/kg STZ mice (high dose, black bar). Values represent the average ± SE. n > 3 per condition. *p < 0.05 compared to control.